Neurogene (NGNE)
NASDAQ:NGNE
US Market
Holding NGNE?
Track your performance easily

Neurogene (NGNE) Stock Investors

440 Followers
Based on 766,063 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NGNE
On average, investors allocate 0.00% of their portfolios to NGNE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 766,063 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NGNE

7.3%
Last 7
Days
14.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NGNE, out of 766,063 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NGNE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,650 investors who made their portfolios public
The table shows changes in NGNE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NGNE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.92%
+3.38%
+5.29%
7.63B
Healthcare
DraftKings
5.42%
+1.54%
-0.28%
35.26B
Consumer Cyclical
Plug Power
5.21%
-0.22%
+0.10%
1.81B
Industrials
Bristol-Myers Squibb
3.47%
-0.39%
-2.23%
109.81B
Healthcare
Enphase Energy
4.60%
-0.90%
+3.47%
9.04B
Technology
Abbott Laboratories
3.56%
+0.47%
+13.13%
202.22B
Healthcare
XPeng, Inc. ADR
5.58%
-1.02%
-1.03%
13.95B
Consumer Cyclical
RTX
4.19%
+3.38%
+6.34%
164.45B
Industrials
CVS Health
3.96%
-0.66%
-0.26%
69.89B
Healthcare
Carnival
6.49%
+3.60%
+8.80%
30.17B
Consumer Cyclical
Based on the activity of 766,063 active portfolios
Open your Smart Portfolio

NGNE Investor Analysis

NGNE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.7%
of NGNE holders
are under 35
Average Segment Performance
Average P/E Ratio26.57
Beta9.43
Dividend Yield51.54%
NGNE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
56.3%
of NGNE holders
are between 35–55
Average Segment Performance
Average P/E Ratio24.84
Beta18.28
Dividend Yield25.17%
NGNE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.0%
of NGNE holders
are over 55
Average Segment Performance
Average P/E Ratio23.97
Beta8.44
Dividend Yield41.02%
Overview of age group and performance of NGNE stock investors
See who invests in NGNE according to age group and performance.

FAQ

How many retail Investors hold NGNE?
<0.1% of TipRanks' retail investors hold NGNE in their portfolios.
    What is NGNE Investor Sentiment?
    NGNE’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of NGNE in the last 7 days?
      ▲ 7.3% of TipRanks' retail investors changed their holding of NGNE in the last 7 days.
        What percentage of retail investors changed their holding of NGNE in the last 30 days?
        ▲ 14.6% of TipRanks' retail investors changed their holding of NGNE in the last 30 days.
          What is the average age of retail investors who hold NGNE?
          The average age of NGNE Holders is between 35–55.
            What other stocks have NGNE investors also bought?
            NGNE Investors also bought VKTX, DKNG, PLUG, BMY, ENPH, ABT, XPEV, RTX, CVS, CCL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AAgilent
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis